Select Page
Rx.Health Platform Powers American Gastroenterological Association Unique Patient Centered National Registry with 65 sites

Rx.Health Platform Powers American Gastroenterological Association Unique Patient Centered National Registry with 65 sites

Rx.Health’s leading digital medicine platform is now enabling the Mount Sinai AppLab and the American Gastroenterology Association to collect electronic Patient Reported Outcomes (e-PROs) for an NIH-Funded Registry for Fecal Microbiota Transplantation (FMT). The FMT registry is expected to enroll and engage with 4000 patients from 65 sites in leading healthcare systems throughout North America over the next 10 years.

This collaboration is a great model of how Rx.Health can partner with medical societies and industry to create customized digital care and research plans. By using its proprietary AI and Clinical Rules Engine Rx.Health creates a continuous engagement model, reduces drop-outs, and enables the collection of real world evidence from patient and device generated data for novel devices, drugs, and digital therapeutics.To Learn more, contact engage@Rx.Health

 

Rx.Health Unveils GI Digital Medicine Toolkit, Presents Results of Two-Year HealthPROMISE Clinical Trial at Digestive Disease Week 2018

Rx.Health Unveils GI Digital Medicine Toolkit, Presents Results of Two-Year HealthPROMISE Clinical Trial at Digestive Disease Week 2018

As digital medicine continues to serve as a driving force in the evolution of patient care, Rx.Health is announcing, in partnership with the AppLab at Mount Sinai, the release of a transformative Gastrointestinal Digital Medicine Toolkit at Digestive Disease Week 2018 in Washington, DC.  This end-to-end solution is the first of its kind in the field of gastroenterology, and allows both patients and providers to realize the myriad of benefits from combining multiple proven and complimentary digital solutions in a single toolkit for GI diseases and endoscopy procedures.

The Toolkit allows providers to prescribe patients a care plan that evolves with the patient’s condition.  Included in the offering are clinically-proven tracking apps, telemedicine support services, scheduling and feedback reminders, as well as solutions that provide a holistic approach to patient care, such as patient social outreach engagement and ongoing health education materials.  An additional core component of the Toolkit is HealthPROMISE, an app-based platform developed at Mount Sinai that is designed to improve the quality of care for those patients struggling with inflammatory bowel disease.

When asked about the significance of the GI Digital Medicine Toolkit, Pavan Choksi, who serves as Rx.Health’s Vice President of Corporate Development and Transformation Lead, noted that “Digital Medicine presents a unique opportunity for providers to treat patients on a continual basis, and not just during office hours.  But like anything, you need the right mechanism in place to do this effectively.  The Toolkit combines the strongest offerings that are complimentary with one another to optimize not just procedural outcomes, but also the general patient experience.”

In conjunction with the release of the GI Digital Medicine Toolkit, Mount Sinai’s AppLab will be presenting the results of a two-year clinical trial of HealthPROMISE on Saturday, June 2nd, at the Mount Sinai Booth at DDW.  In addition to the presentation, representatives from AppLab will also be demonstration of the unique GI BOT.  Please stop by booth #1407 to discuss how digital medicine could transform your practice or care.